Human FABP4/A-FABP/AFABP ORF/cDNA clone-Lentivirus plasmid (NM_001442)
Cat. No.: pGMLP000634
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human FABP4/A-FABP/AFABP Lentiviral expression plasmid for FABP4 lentivirus packaging, FABP4 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
Our GM-Lentiviral vector is seamlessly integrated with the GM lentivirus packaging system. Discover more about the GM lentivirus packaging system.
Go to
FABP4/A-FABP products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
| Catalog ID | pGMLP000634 |
| Gene Name | FABP4 |
| Accession Number | NM_001442 |
| Gene ID | 2167 |
| Species | Human |
| Product Type | Lentivirus plasmid (overexpression) |
| Insert Length | 399 bp |
| Gene Alias | A-FABP,AFABP,ALBP,aP2,HEL-S-104 |
| Fluorescent Reporter | ZsGreen |
| Mammalian Cell Selection | Puromyocin |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | CMV |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGTGTGATGCTTTTGTAGGTACCTGGAAACTTGTCTCCAGTGAAAACTTTGATGATTATATGAAAGAAGTAGGAGTGGGCTTTGCCACCAGGAAAGTGGCTGGCATGGCCAAACCTAACATGATCATCAGTGTGAATGGGGATGTGATCACCATTAAATCTGAAAGTACCTTTAAAAATACTGAGATTTCCTTCATACTGGGCCAGGAATTTGACGAAGTCACTGCAGATGACAGGAAAGTCAAGAGCACCATAACCTTAGATGGGGGTGTCCTGGTACATGTGCAGAAATGGGATGGAAAATCAACCACCATAAAGAGAAAACGAGAGGATGATAAACTGGTGGTGGAATGCGTCATGAAAGGCGTCACTTCCACGAGAGTTTATGAGAGAGCATAA |
| ORF Protein Sequence | MCDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDVITIKSESTFKNTEISFILGQEFDEVTADDRKVKSTITLDGGVLVHVQKWDGKSTTIKRKREDDKLVVECVMKGVTSTRVYERA |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Target Antibody | GM-Tg-g-T07217-Ab | Anti-FABP4 monoclonal antibody |
| Target Antigen | GM-Tg-g-T07217-Ag | FABP4 protein |
| ORF Viral Vector | pGMLP000634 | Human FABP4 Lentivirus plasmid |
| ORF Viral Vector | pGMPC000894 | Human FABP4 Mammalian (Non-Viral Vector) plasmid |
| ORF Viral Vector | vGMLP000634 | Human FABP4 Lentivirus particle |
Target information
| Target ID | GM-T07217 |
| Target Name | FABP4 |
|
Gene Group Identifier (Target Gene ID in Homo species) |
2167 |
| Gene ID |
101087449 (Felis catus), 11770 (Mus musculus), 2167 (Homo sapiens), 608476 (Canis lupus familiaris) 701365 (Macaca mulatta), 79451 (Rattus norvegicus) |
| Gene Symbols & Synonyms | FABP4,Fabp4,Ap2,P15,ALBP,Lbpl,AFABP,422/aP2,ALBP/Ap2,aP2,A-FABP,HEL-S-104,Albp |
| Target Alternative Names | 422/aP2,A-FABP,AFABP,AFABP),ALBP,ALBP/Ap2,Adipocyte lipid-binding protein (ALBP),Adipocyte-type fatty acid-binding protein (A-FABP,Albp,Ap2,FABP4,Fabp4,Fatty acid-binding protein,Fatty acid-binding protein 4,HEL-S-104,Lbpl,P15,aP2,adipocyte |
| Uniprot Accession |
P04117,P15090,P70623
Additional SwissProt Accessions: P04117,P15090,P70623 |
| Uniprot Entry Name | |
| Protein Sub-location | Introcelluar Protein |
| Category | Therapeutics Target |
| Disease | Bladder Cell Carcinomas |
| Disease from KEGG | PPAR signaling pathway, Regulation of lipolysis in adipocytes |
| Gene Ensembl | ENSMUSG00000062515, ENSG00000170323, ENSCAFG00845014963, ENSMMUG00000020987 |
| Target Classification |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


